Sovateltide is under clinical development by Pharmazz and currently in Phase I for Hypoxic-Ischemic Encephalopathy.

Talfirastide is under clinical development by Constant Therapeutics and currently in Phase II for Ischemic Stroke.

The association between hospital-diagnosed migraine and increased risks to cardiovascular health cannot be attributed to ...

Obstructive lung disease; subpleural consolidation, including one confirmed lung cancer; minimal pleural effusion; and ischemic cardiac disease were included as additional findings (11 ...

The growing use of artificial intelligence is causing significant changes around the world, with the medical field also ...

Having the occasional pastry or sweet treat may not raise cardiovascular disease risk but sugar-sweetened drinks such as sodas can significantly, a new study finds.

HC Wainwright restated their buy rating on shares of BioCardia (NASDAQ:BCDA – Free Report) in a research report released on Wednesday morning,Benzinga reports. They currently have a $25.00 target ...

HBO founder Charles Dolan dies at 98 due to natural causes Read ahead to know more about his legacy and the causes of natural ...

Life expectancy in the United States is worse than in many other countries and declined from 1990 to 2021, data suggest.

Dec. 04, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced ...

The deadliest disease in the world is Coronary Artery Disease (CAD), which is also called “Ischemic Heart Disease ... This is ...